查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1524283

生物材料伤口敷料市场- 材料类型（天然[藻酸盐、胶原蛋白]、合成[聚氨酯、硅]）、应用（慢性[压力、糖尿病溃疡]、急性[手术和外伤伤口、烧伤]）、最终用户- 全球预测(2024 - 2032)

Biomaterial Wound Dressing Market - Material Type (Natural [Alginate, Collagen], Synthetic [Polyurethane, Silicon]), Application (Chronic [Pressure, Diabetes Ulcer], Acute [Surgical & traumatic wounds, Burns]), End-user - Global Forecast (2024 - 2032)
出版日期: | 出版商: Global Market Insights Inc. | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

受生物材料和伤口敷料技术进步以及对个人化和创新伤口护理解决方案不断增长的需求的推动，2024年至2032年全球生物材料伤口敷料市场规模将创下6.4%的复合年增长率。这些进步提供了增强的功能、改进的生物相容性以及客製化的解决方案，以满足不同患者的需求。

随着医疗保健的重点转向以患者为中心的护理模式和基于价值的结果，能够加快康復过程并最大限度地减少并发症的更先进的敷料将会出现，进一步推动市场扩张。例如，2024年3月，IASST阿萨姆邦的科学家生产了一种廉价的环保绷带材料，该材料由香蕉纤维与壳聚醣和瓜尔胶混合製成。

生物材料伤口敷料产业分为材料类型、应用、最终用户和地区。

根据材料类型，由于其多功能性和先进性能，到 2032 年，合成材料领域将经历利润丰厚的成长。随着聚合物科学和工程的发展，合成敷料提供了客製化的解决方案，例如与活体组织的高相容性、抗磨损或损坏的强度以及灵活性。此外，这些物质可以模仿组织的自然特性，同时在癒合伤口方面提供更好的效果。

从最终用户来看，由于门诊手术的偏好和效率不断提高，门诊手术中心领域的生物材料伤口敷料市场到 2032 年将大幅复合年增长率。门诊手术适合生物材料敷料，因为它们符合其特定要求，包括有效的伤口管理、更快的癒合时间和更少的术后併发症。对微创治疗方案的兴趣日益浓厚也将有利于该细分市场的成长。

亚太地区生物材料伤口敷料产业将在2024年至2032年间实现显着的复合年增长率。此外，各国政府的措施旨在加强现代医疗基础设施和新医疗技术的采用。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 慢性伤口的发生率增加
      • 老年人口不断增加
      • 事故数量不断增加
      • 伤口敷料的技术进步
    • 产业陷阱与挑战
      • 有限的报销政策
  • 成长潜力分析
  • 未来市场趋势
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按材料类型，2021 - 2032 年

  • 主要趋势
  • 自然的
    • 海藻酸盐
    • 胶原
    • 壳聚醣
    • 羧甲基纤维素（CMC）
    • 其他天然材料
  • 合成的
    • 聚氨酯
    • 硅
    • 聚乙烯醇
    • 其他合成材料

第 6 章：市场估计与预测：按应用分类，2021 - 2032

  • 主要趋势
  • 慢性伤口
    • 压疮
    • 糖尿病足溃疡
    • 腿部静脉性溃疡
    • 其他慢性伤口
  • 急性伤口
    • 手术伤口及外伤伤口
    • 伯恩斯

第 7 章：市场估计与预测：按最终用户划分，2021 - 2032 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 家庭护理设置
  • 其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 9 章：公司简介

  • 3M
  • B. Braun Melsungen AG
  • ConvaTec Group plc
  • DermaRite Industries LLC
  • Hollister Incorporated
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic plc
  • Molnlycke Health Care AB
  • Smith & Nephew plc
简介目录
Product Code: 9297

Global bio material Wound Dressing Market size will record 6.4% CAGR from 2024 to 2032, propelled by technological advancements in bio materials and wound dressing technologies coupled with the growing demand for personalized and innovative wound care solutions. These advancements are offering enhanced functionalities, improved bio compatibility, and tailored solutions for catering to diverse patient needs.

As the focus of the healthcare shifts towards patient-centered care models plus value-based outcomes, more advanced dressings capable of speeding up recovery processes and minimize complications will come to light, further driving the market expansion. For example, in March 2024, scientists at IASST Assam produced a cheap environmentally friendly bandage material made by blending banana fibers with chitosan and guar gum.

The bio material wound dressing industry is fragmented into material type, application, end-user, and region.

Based on material type, the synthetic segment will experience lucrative growth by 2032 due to its versatility and advanced properties. With the developments in polymer science and engineering, synthetic dressings provide tailored solutions like high compatibility with living tissue, strength against wear or damages and flexibility. Moreover, these substances can imitate natural characteristics of tissues while giving better outcomes in healing wounds.

By End-User, the bio material wound dressing market from the ambulatory surgical centers segment will witness substantial CAGR through 2032, owing to their growing preference and efficiency in outpatient procedures. Ambulatory surgery suits bio material dressings as they meet its specific requirements including effective wound management, faster healing time, and fewer post-operative complications. The rising interest in less invasive treatment options will also favor the segment growth.

Asia Pacific bio material wound dressing industry will achieve a remarkable CAGR between 2024 and 2032. This can be attributed to rapid population growth, the prevalence of chronic wounds alongside the increase in healthcare spending. Additionally, initiatives by governments are aiming to enhance modern healthcare infrastructure and the uptake of new medical technologies The aging people and the rise of medical tourism will also fuel the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of chronic wound
      • 3.2.1.2 Rising geriatric population
      • 3.2.1.3 Increasing number of accidents
      • 3.2.1.4 Technological advancements in wound dressings
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Limited reimbursement policies
  • 3.3 Growth potential analysis
  • 3.4 Future market trends
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Material Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Natural
    • 5.2.1 Alginate
    • 5.2.2 Collagen
    • 5.2.3 Chitosan
    • 5.2.4 Carboxymethyl cellulose (CMC)
    • 5.2.5 Other natural materials
  • 5.3 Synthetic
    • 5.3.1 Polyurethane
    • 5.3.2 Silicon
    • 5.3.3 Polyvinyl alcohol
    • 5.3.4 Other synthetic materials

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Chronic wounds
    • 6.2.1 Pressure ulcers
    • 6.2.2 Diabetic foot ulcers
    • 6.2.3 Venous leg ulcers
    • 6.2.4 Other chronic wounds
  • 6.3 Acute wounds
    • 6.3.1 Surgical & traumatic wounds
    • 6.3.2 Burns

Chapter 7 Market Estimates and Forecast, By End-User, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Home care settings
  • 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 3M
  • 9.2 B. Braun Melsungen AG
  • 9.3 ConvaTec Group plc
  • 9.4 DermaRite Industries LLC
  • 9.5 Hollister Incorporated
  • 9.6 Integra LifeSciences Holdings Corporation
  • 9.7 Johnson & Johnson
  • 9.8 Medtronic plc
  • 9.9 Molnlycke Health Care AB
  • 9.10 Smith & Nephew plc